Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MMJ Group Holdings
Western Australia, Australiammjgh.com.au ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
MMJ Group Holdings transitioned from operating as a vertically integrated cannabis biotechnology company to a cannabis-focused listed investment company. As an owner-operator, it advanced oral delivery technologies for medical cannabis and had several programs move into commercial distribution of cannabinoid-based products, with clinical results supporting efficacy for specific products in pain and epilepsy. Since 2018, it no longer develops therapies directly but holds minority investments in multiple cannabis-related entities worldwide, leveraging its prior R&D and regulatory expertise.[4][5]
- Therapeutic areas
- NeurologyOther
- Modalities
- Small moleculeBiologic
- Industry
- Investors
02
Partnerships
Yissum (Hebrew University tech transfer)
Beyond the preview
Go deeper on MMJ Group Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MMJ Group Holdings.